Corporate ActionJun 8, 2026, 08:02 AM
BioCardia Sells 3.5M Shares at $1.279; Extends Cash Runway
AI Summary
BioCardia, Inc. announced the sale of 3,509,604 shares at an average price of $1.279 per share, generating approximately $4.49 million in net proceeds. This capital raise is expected to extend the company's cash runway into the first quarter of 2027, beyond the anticipated Japan PMDA submission. The company also noted that the full exercise of currently outstanding warrants could further extend the cash runway well beyond PMDA approval and into initial commercial sales.
Key Highlights
- BioCardia sold 3,509,604 shares of common stock.
- Shares were sold at an average price of $1.279 per share.
- The capital raise generated approximately $4.49 million in net proceeds.
- Proceeds are anticipated to extend the cash runway into Q1 2027.
- Cash runway extension is beyond the expected Japan PMDA submission.
- Full exercise of outstanding warrants could extend cash runway beyond PMDA approval and into first commercial sales.
- Upcoming catalyst includes CardiAMP HF Japan PMDA Submission in Q4 2026.
Price Impact
More from BCDA